Closing Bell: Market Recovers To End With Mild Gains; HDFC Bank & ICICI Bank Lend Support To Nifty

In a day marked by volatility, the Indian stock market witnessed a notable recovery led by strong performances from financial sectors. The Sensex and Nifty, after experiencing intra-day dips, managed to stage a smart recovery, closing higher by 112 points and 49 points respectively. This resurgence was largely attributed to the robust performance of key players in the financial realm, particularly HDFC Bank and ICICI Bank, which collectively contributed 80% to the gains observed in both Nifty and Nifty Bank.

Alongside the financials, the pharmaceutical sector also saw significant buying activity following positive commentary from Cipla. This added momentum helped bolster the market sentiment and contributed to the overall positive closure of the indices. Notable pharmaceutical stocks, including Lupin, witnessed a surge after a US court lifted a restraining order, providing a boost to their shares.

Despite initial concerns and a skewed advance-decline ratio of 1:5 favouring declines, the market breadth showed signs of improvement intra-day, with the ratio evening out to 1:1 by the close. This shift indicated a more balanced trading landscape, mitigating some of the early losses experienced during the session.

However, amidst the recovery, the volatility index recorded a notable uptick, rising by 12% to reach its highest level in 19 months, reminiscent of levels last seen in October 2022. This increase in volatility reflects the uncertainty prevailing in the market, potentially attributed to various factors including global economic concerns and domestic uncertainties.

UPL saw buying interest following strong Q4 earnings and an optimistic outlook, pushing the stock up by 6%. Conversely, Tata Motors faced pressure due to a cautious outlook, slipping by 8% and emerging as the top Nifty loser. PSU companies remained volatile, particularly tracking ongoing elections, with OMCs managing to recover from earlier lows by the session's close.

On the back of a robust set of earnings, ABB soared by up to 11%, consequently lifting allied stocks such as Siemens and Cummins. This positive sentiment surrounding ABB's performance contributed to the overall bullish outlook in the market.

Conversely, Union Bank faced downward pressure, slipping by 8% following reports of increased slippages and lower operating profit. Zomato, although ending lower, managed to recover significantly from earlier lows, supported by an improved set of earnings.

Polycab continued its upward trajectory, building on Friday's gains and hitting a record high on the back of healthy Q4 earnings. Similarly, Dr Lal PathLabs witnessed a 6% rise fueled by positive management commentary, while Metropolis also saw buying interest.

The Indian stock market witnessed varied movements across different sectors. While the BSE Midcap index managed to eke out a 0.3% gain, the BSE Smallcap index dipped by 0.2%, reflecting the divergent trends prevalent in the broader market.

Nine out of 13 major sectoral indices closed in the green on May 13, with Nifty Pharma and Nifty Healthcare emerging as the top gainers, each surging nearly 2%. Notably, the pharmaceutical sector saw a boost driven by positive sentiments surrounding Cipla.

In contrast, the Nifty Auto index witnessed significant downward pressure, shedding 1.5% during the session. Tata Motors, in particular, weighed heavily on the sector.

A combination of factors continues to influence market dynamics, including a mixed earnings season, apprehensions surrounding election outcomes, and selling pressure from Foreign Institutional Investors (FIIs). These factors have contributed to the prevailing cautious sentiment among investors. Key developments to monitor this week include US and India Consumer Price Index (CPI) data releases, along with ongoing corporate earnings announcements, which are expected to further shape market trends.

Investors remain vigilant, closely monitoring both domestic and global developments. While certain sectors like pharmaceuticals exhibit resilience, others such as automotive face challenges. The coming days are likely to witness continued volatility as market participants assess incoming data and corporate performance.